Dr Sanil Rege FRANZCP | MRCPsych Profile picture
Nov 2, 2024 10 tweets 4 min read Read on X
🧵 1/ This is the mu-opioid receptor 🧵
It plays a crucial role in attachment, reward, social bonding and pain.
🚀Understanding Borderline Personality Disorder (BPD) as an Interpersonal Pain Syndrome 👇Image
1/ BPD and Pain Sensitivity: Evidence shows that individuals with BPD often present atypical pain responses, with up to 80% displaying reduced pain perception during non-suicidal self-injury (NSSI) episodes.
This phenomenon may stem from opioidergic system dysregulation, where neurobiological shifts alter pain processing in the brain.
2/Chronic Pain and BPD: Studies reveal that up to 65% of BPD patients experience chronic pain, which not only exacerbates emotional dysregulation but also predicts lower likelihood of remission.
3/ EOS and Emotional Dysregulation: The Endogenous Opioid System (EOS)- a neuromodulatory network crucial for mood, reward, and social bonding- plays a key role in BPD.
Components like mu-opioid receptors (MOR) and kappa-opioid receptors (KOR) modulate pleasure, pain, and the stress response, forming the foundation of pain abnormalities in BPD.Image
4/ In typical pain processing, MORs provide analgesia and reward signals, while KORs contribute to stress-induced dysphoria.
Childhood trauma and chronic stress disrupt this balance, often leading to hypomethylation of the OPRK1 gene, which boosts KOR expression and contributes to the emotional numbness and dysphoria characteristic of BPD.Image
5/ Reduced MOR Activity: Neglect or social isolation can lead to under-stimulated MORs, impairing emotional bonding and reward processing.

To compensate, individuals with BPD might turn to behaviours like substance use or self-injury as attempts to restore EOS activity and alleviate emotional pain.

Clinical implications: Clinical trials involving opioid antagonists, such as naltrexone and buprenorphine (KOR antagonist), have shown promising results in reducing self-harming behaviours by blunting the rewarding effects typically associated with these actions.Image
7/ Interpersonal Pain and Neuroadaptation in BPD: The Allostatic and CReAM Models

Initially, relational stress potentiates dopaminergic trafficking, but over time, prolonged stress shifts patients into a Reward Deficiency (RD) state marked by anhedonia and low motivation.
Neuroadaptations involving the amygdala and brainstem elevate CRF, norepinephrine, and dynorphin, reinforcing an Anti-Reward (AR) State and compounding chronic psychological pain.Image
8/ Engel’s Lens on Pain: Developmental Roots of Relational Instability in BPD:

"We discover that in the course of the child’s development, pain and relief of pain enter into the formation of interpersonal (object) relations and into the concepts of good and bad, reward and punishment, success and failure. Pain becomes par excellence a means of assuaging guilt and thereby influences object relationships". [Engel, 1959]

In Borderline Personality Disorder (BPD), this link is important as early disruptions in processing pain and comfort within relationships can lead to heightened sensitivity to rejection and a cycle of relational instability.
9/Zanarini’s Perspective: The “Pain of Being Borderline” :
Zanarini et al. highlighted that individuals with Borderline Personality Disorder (BPD) experience 25 distinct forms of distress that are far more prevalent in BPD than in other conditions.
This interpersonal pain may reinforce a “medical victim” identity, where relational distress becomes central to how individuals with BPD experience and seek relief from pain. [Sansone and Sansone, 2007]
This is a little glimpse from the comprehensive review of the Neurobiology and Psychodynamics of BPD.
Full article 👉psychscenehub.com/psychinsights/…

For clinicians, consider the courses (including the psychodynamic psychotherapy courses on the Academy ) 👉academy.psychscene.com Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Sanil Rege FRANZCP | MRCPsych

Dr Sanil Rege FRANZCP | MRCPsych Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sanilrege

Feb 12
🧵Cannabis Can Make You Vomit. Hot Showers Can Stop It. Why?🚨

Let’s explore 1/10 👇 Image
1/ In cannabinoid hyperemesis syndrome (CHS), patients often report compulsive hot showers or baths that temporarily relieve severe nausea and vomiting.

This pattern is so consistent it’s now considered a diagnostic clue.
2/ The link is TRPV1.

TRPV1 (Transient Receptor Potential Vanilloid 1) is a polymodal cation channel activated by:

• Noxious heat (>43°C)
• Capsaicin (chilli)
• Acidic/inflammatory states

TRPV1 is heavily expressed on peripheral nociceptive fibres but also interfaces with central circuits involved in emesis and interoception.Image
Read 11 tweets
Feb 2
🧵This drug modulates mitochondria. It might change psychiatric treatment ! 🚨1/7

Introducing Trimetazidine ✅

It’s not new.

Trimetazidine comes from anti-angina treatment built on a simple metabolic principle

Let’s explore 👇 Image
1/ Lessons from angina -

-In angina, the myocardium isn’t short of fuel - it’s short of oxygen-efficient ATP production.

-Fatty-acid oxidation yields more ATP per gram, but:

-consumes more oxygen
-generates more oxidative stress
-is slower for rapid ATP needs under stress

Image modified from -slideshare.net/slideshow/angi…Image
2/ The solution

- shift fuel use from fatty-acid oxidation → glucose oxidation (same ATP, lower oxygen cost, less oxidative burden).
Read 8 tweets
Jan 31
🧵What are the differences between Ketamine and Memantine - 🚨1/7

Both are NMDA antagonists - But with different clinical effects.

Here’s why 👇 Image
1/ Receptor selectivity

-Memantine → preferentially blocks extrasynaptic NMDARs (excitotoxic signalling)

-Ketamine → blocks synaptic + extrasynaptic NMDARs

- Ketamine is non-selective (muscarinic, monoaminergic, opioid effects → psychotomimetic profile)
2/ Affinity & channel behaviour

- Memantine: moderate affinity, fast unblocking, activity-dependent

- Ketamine: higher affinity, longer channel occupancy

Clinical relevance :
Memantine disengages during normal synaptic activity → good tolerability.

Ketamine’s longer occupancy contributes to dissociation and perceptual effects.
Read 8 tweets
Jan 28
🧵A process in cancer may hold clues for psychiatry. 🚨1/10

Let’s talk about the Warburg Effect 👇 Image
1/ In cancer, one of the earliest changes isn’t a mass or a tumour.

It’s a metabolic shift.

Despite oxygen being available, ~70–80% of cancers switch from efficient mitochondrial respiration to aerobic glycolysis.

This is the Warburg effect first described over a century ago.
2/ Why would a cell choose an inefficient energy pathway?

Because glycolysis is:
– Faster
– Flexible
– Supplies building blocks (DNA, lipids, amino acids)

It supports survival, proliferation, and resistance under biological stress.

It’s no longer about efficiency ; it’s about survival.Image
Read 6 tweets
Jan 13
🧵Is treatment response to Stimulants ‘mis’...leading to ADHD misdiagnoses? Pathomodal vs Physiomodal? 🚨1/15

Vyvanse has now overtaken Ozempic as the most prescribed agent in Australia.

That fact alone should make us pause. 🚨 Image
1/ Prof Michael Berk has just published an important editorial in the British Journal of Psychiatry that articulates something many clinicians feel but rarely name.

It’s about treatment response and how it quietly shapes diagnosis Image
2/ As Prof Berk writes:

“A clinically critical but conceptually ignored step in clinical diagnosis is response to treatment.”

We don’t include it in diagnostic criteria but in practice, it carries enormous weight.
Read 16 tweets
Jan 12
🧵Antidepressants don’t act on a unitary construct called “misery”.🚨1/11

They act on various systems.

Fear.
Salience.
Reward.
Cognition.
Pain.
Inflammation.
Arousal.
Behavioural activation…..etc

That distinction matters.

Let me explain 👇
1/ These medications are multifaceted in their mechanisms of action that allow the pharmacologist to target specific domains.

Like Metformin, GLP-1 agonists, SGLT2 inhibitors, etc, we've moved away from 'antidiabetics' to greater nuance.

So let's look at 'Antidepressants' and the various MOAsImage
2/ Modulation of threat and fear circuits:

-Amygdala–ACC threat processing
-DRN-mediated fear and anxiety signalling

Reducing threat salience ≠ improving mood ≠ restoring motivation.

These are distinct targets. Image
Read 12 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(